Document Detail


Do angiotensin II type 1 receptor blockers have molecular effects?
MedLine Citation:
PMID:  19942930     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Shin-Ichiro Miura; Keijiro Saku
Publication Detail:
Type:  Comment; Journal Article     Date:  2009-11-27
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  33     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-08     Completed Date:  2010-04-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  105-6     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan. miuras@cis.fukuoka-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / blood
Angiotensin II Type 1 Receptor Blockers / pharmacology*
Extracellular Signal-Regulated MAP Kinases / metabolism
Humans
Peptidyl-Dipeptidase A / genetics
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 11128-99-7/Angiotensin II; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases; EC 3.4.15.1/Peptidyl-Dipeptidase A; EC 3.4.17.-/angiotensin converting enzyme 2
Comments/Corrections
Comment On:
Hypertens Res. 2010 Feb;33(2):118-22   [PMID:  19927151 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zinc-finger transcriptional factor Sall1 induces angiogenesis by activation of the gene for VEGF-A.
Next Document:  Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human pl...